We are an R&D company that comprehensively fights mycoplasma infectious disease (MID) The mechanical and physiological properties of mycoplasma have made its detection challenging. Recent studies have shown that mycoplasma is not merely a "cold", but is also directly linked to a variety of conditions. Conditions previously thought to be unrelated such as rheumatism, heart disease, and neurological disease appear to manifest as a result of mycoplasma infections Our patented technology is able to identify, analyze and synthesize the antigen present on the surface membrane of mycoplasma. We are developing "MID Prism", to monitor the disease. We aim to further develop this platform for vaccine development and disease treatment.
info@mbiotechnology.com
